<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Overexpression Cohesion Establishment Factor DSCC1 <br /> through E2F Colorectal <span id='am-44' about='obo:NCBITaxon_6754' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_72041 obo:NCBITaxon_33154 obo:NCBITaxon_6681 obo:NCBITaxon_6682 obo:NCBITaxon_6683 obo:NCBITaxon_29964 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_116706 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_6753 obo:NCBITaxon_88770 obo:NCBITaxon_6752'><span id='am-45' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-46'  ></span><span id='am-47' property="rdfs:label" content="Cancer" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Cancer</span> <br /> Kiyoshi Yamaguchi1*, Rui Yamaguchi2, Norihiko Takahashi1, Tsuneo Ikenoue1, Tomoaki Fujii1, <br /> Masaru Shinozaki3, Giichiro Tsurita3, Keisuke Hata3, Atsushi Niida4, Seiya Imoto4, Satoru Miyano2,4, <br /> Yusuke Nakamura5, Yoichi Furukawa1 <br /> 1 Division Clinical Genome Research, Advanced Clinical Research Center, Institute Medical Science, The University Tokyo, Tokyo, Japan, 2 Laboratory Sequence <br /> Analysis, Human Genome Center, Institute Medical Science, The University Tokyo, Tokyo, Japan, 3 Department Surgery, Research Hospital, Institute Medical <br /> Science, The University Tokyo, Tokyo, Japan, 4 Laboratory DNA Information Analysis, Human Genome Center, Institute Medical Science, The University Tokyo, <br /> Tokyo, Japan, 5 Laboratory Molecular Medicine, Human Genome Center, Institute Medical Science, The University Tokyo, Tokyo, Japan <br />  <br />  <br />  <br />      Abstract <br />      Ctf18-replication factor C complex including Dscc1 (DNA replication sister chromatid cohesion 1) implicated sister <br />      chromatid cohesion, DNA replication, genome stability S. cerevisiae C. elegans. We previously performed gene <br />      expression profiling primary colorectal cancer cells <span id='am-80' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-81' property="rdfs:label" content="order" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>order</span> identify novel molecular targets treatment of <br />      colorectal cancer. A feature cancer-associated transcriptional signature revealed effort elevated <br />      expression proto-oncogene DSCC1. Here, interrogated molecular basis deviant expression human <br />      DSCC1 colorectal cancer ability promote survival cancer cells. Quantitative PCR immunohistochemical <br />      analyses corroborated expression level DSCC1 elevated 60&#8211;70% colorectal tumors compared their <br />      matched noncancerous colonic mucosa. An silico evaluation presumptive DSCC1 promoter region consensus <br />      DNA transcriptional regulatory elements revealed potential role E2F <span id='am-41' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-42' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="family" datatype="xsd:string"></span>family</span> DNA-binding proteins controlling <br />      DSCC1 expression. RNAi-mediated reduction E2F1 reduced expression DSCC1 colorectal cancer cells. Gain- loss- <br />      of-function experiments demonstrated DSCC1 involved viability cancer cells response genotoxic <br />      stimuli. We reveal E2F-dependent expression DSCC1 confers anti-apoptotic properties colorectal cancer cells, and <br />      suppression useful option treatment colorectal cancer. <br />  <br />   Citation: Yamaguchi K, Yamaguchi R, Takahashi N, Ikenoue T, Fujii T, et al. (2014) Overexpression Cohesion Establishment Factor DSCC1 E2F in <br />   Colorectal Cancer. PLoS ONE 9(1): e85750. doi:10.1371/journal.pone.0085750 <br />   Editor: Srikumar P. Chellappan, H. Lee Moffitt Cancer Center &amp; Research Institute, United States America <br />   Received October 28, 2013; Accepted November 30, 2013; Published January 17, 2014 <br />   Copyright: &#223; 2014 Yamaguchi et al. <span id='am-67' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-68' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-69' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-70'  ></span><span id='am-71' property="rdfs:label" content="This" datatype="xsd:string"></span>This</span> open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: This work supported Grant-in-Aid Young Scientists (#23790126), MEXT/JSPS, Japan K. Yamaguchi, Global COE Program <br />   &#8216;&#8216;Center education research advanced genome-based medicine personalized medicine control worldwide infectious diseases&#8217;&#8217;, MEXT/ <br />   Japan Society Promotion Science, Japan Y. Furukawa. The funders role study design, <span id='am-83' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-84'  ></span><span id='am-85' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-87' property="rdfs:label" content="Data" datatype="xsd:string"></span>data</span> collection analysis, decision publish, or <br />   preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * E-mail: kiyamagu@ims.u-tokyo.ac.jp <br />  <br />  <br />  <br /> Introduction                                                                           NIPBL, STAG3, homologues yeast SMC1, SMC3, <br />                                                                                        SCC2, SCC3, respectively) [3]. Since sister chromatid cohesion <br />    Colorectal cancer (CRC) frequent human                           indispensable cellular processes chromosome <br /> neoplasms world. In CRC cells, disruption systems                            segregation, homologous recombinational repair, regulation <br /> governing genetic epigenetic integrity renders different features                   transcription [4], genetic alterations components and <br /> such chromosomal instability (CIN), microsatellite instability                      regulators play crucial role CIN colorectal <br /> (MSI), CpG island methylator phenotype (CIMP). A great                             tumors. <br /> majority colorectal tumors exhibit CIN includes gross                             We previously performed gene expression profile analysis in <br /> genetic changes deletions, amplifications, inversions,                         CRC [5], identified DNA replication sister <br /> rearrangements, gain loss large portions                             chromatid cohesion 1 (DSCC1, known DCC1) was <br /> chromosomes, translocations [1]. An earlier study identified                       frequently elevated colorectal tumors compared non- <br /> somatic mutations genes including MRE11, ZW10, <br />                                                                                        cancerous colonic mucosa. Dcc1p, homolog DSCC1, first <br /> ZWILCH, ROD, DING, 100 human CIN-candidate <br />                                                                                        identified member alterative replication factor C (RFC) <br /> genes shared similarity yeast fly &#8216;&#8216;instability&#8217;&#8217; genes [2]. <br />                                                                                        complex yeast, physically associates Ctf8p and <br /> Their data suggested functions including <br />                                                                                        Ctf18p [4]. Deletion component, Ctf18p, Ctf8p, Dcc1p, <br /> double-strand break repair, kinetochore function, chromatid <br />                                                                                        resulted severe sister chromatid cohesion defects, increased <br /> segregation, impaired CIN tumors somatic mutation. <br />                                                                                        sensitivity microtubule depolymerizing drugs, suggesting that <br /> Another study searched mutations 102 human homologues <br />                                                                                        components essential maintenance chromatin <br /> of yeast CIN genes 132 colorectal cancers. Consequently, they <br />                                                                                        integrity [4]. Although Dcc1p essential viability of <br /> identified total 11 mutations genes included four <br />                                                                                        yeast, deletion Dcc1p led synthetic lethality combination <br /> associated sister chromatid cohesion (SMC1L1, CSPG6, <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                         1                              January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                  DSCC1 Is Novel Target E2F <br />  <br />  <br /> with mutation sister chromatid cohesion proteins [6]. In           TCAGGTTTCCTACCTTCCGGCTGCTT-39) set of <br /> addition implication sister chromatid cohesion,               primers (forward: 59-GGCGCGCTTTCAAACG-39, reverse: 59- <br /> CTF18-DSCC1-CTF8-RFC complex plays crucial role DNA                    GCGGGCAAGAAAGAAGTTCC-39) DSCC1, TaqMan <br /> replication interaction single-stranded                Copy Number Reference Assays RNase P quantitative control <br /> primed DNA loader proliferating cell nuclear antigen                (Life Technologies). The copy number DSCC1 cancer <br /> [7]. Furthermore, genetic network analysis functionally related          cells calculated comparison genomic DNA from <br /> genes yeast suggested components CTF18-                  healthy volunteers using CopyCaller Software. <br /> DSCC1-CTF8-RFC complex interact MAD/BUB <br /> spindle checkpoint pathway, RAD51 DNA repair pathway                    Subcellular fractionation immunoblotting <br /> for double-strand breaks, RAD9 DNA damage checkpoint,                      Cells lysed radioimmunoprecipitation assay buffer <br /> and TOF1/MRC DNA replication checkpoint pathway [8,9].                  (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% sodium deoxy- <br /> The finding mutation CTF18-RFC increased triplet repeat             cholate, 1% Nonidet P-40, 0.1% SDS) supplemented a <br /> instability corroborated role complex DNA-               Protease Inhibitor Cocktail Set III (Calbiochem, San Diego, CA). <br /> replication checkpoint [10]. These data indicated DSCC1                Nuclear extracts prepared using Nuclear Extract Kit (Active <br /> plays important role replication, spindle checkpoint              Motif, Carlsbad, CA). Proteins separated SDS-PAGE and <br /> DNA repair, prompted investigate deregu-                immunoblot analysis performed using indicated antibod- <br /> lated expression DSCC1 involved human colorectal                   ies. Horseradish peroxidase-conjugated goat anti-mouse anti- <br /> tumorigenesis.                                                              rabbit IgG (GE Healthcare, Buckinghamshire, UK) served the <br />    Here, time DSCC1 frequently up-            secondary antibody ECL Detection System (GE Health- <br /> regulated CRC enhanced                      care). <br /> transcriptional activation E2F. We reveal elevated <br /> expression DSCC1 confers chemoresistance CRC cells by <br /> providing tumor cells anti-apoptotic properties. These                 Immunostaining <br /> findings contribute better understanding CRC,                 Primary antibodies used immunohistochemical immu- <br /> serve starting point development novel strategies       nocytochemical staining anti-DSCC1 (B01P, Abnova, <br /> diagnosis treatment CRC.                                             Taipei, Taiwan) anti-Myc (Sigma). The specificity DSCC1 <br />                                                                             antibody confirmed blocking DSCC1 recombi- <br />                                                                             nant protein (data shown). These experiments performed <br /> Materials Methods <br />                                                                             described previously [11]. <br /> Ethics statement <br />    This project approved ethical committee Institute          Induction apoptosis flow cytometry <br /> of Medical Science, University Tokyo (IMSUT-IRB, 21-14-                 To study induction apoptosis, cells treated with <br /> 0806). Written informed consent obtained patients           camptothecin (Wako, Osaka, Japan), doxorubicin (LC Laborato- <br /> this study. All colorectal cancer tissues corresponding non-            ries, Woburn, MA), MG132 (Merck Millipore, Darmstadt, <br /> cancerous tissues obtained surgical specimens                  Germany), exposed c-irradiation (Gammacell 40, Atomic <br /> patients underwent surgery.                                             Energy Canada, Ontario, Canada). Expression cleaved poly <br />                                                                             (ADP-ribose) polymerase (PARP) cleaved caspase-3 was <br /> Cell culture                                                                detected western blot analysis using anti-cleaved PARP <br />    Human CRC cell lines HCT116, HCT-15, SW480, DLD-1,                       (9541) anti-caspase-3 antibodies (9662), respectively (Cell <br /> LoVo, Caco-2, LS174T, HT-29, RKO purchased                    Signaling Technology, Danvers, MA). Assessment apoptosis was <br /> the American Type Culture Collection (Manassas, VA). All cells              performed annexin V PI double-staining using <span id='am-1' about='obo:NCBITaxon_149625' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_163739 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-2' property="rdfs:label" content="Alexa" datatype="xsd:string"></span><span id='am-3'  ></span><span id='am-4' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Alexa</span> <br /> were grown appropriate media supplemented FBS (Life                 Fluor 488 Annexin V/Dead Cell Apoptosis Kit (Life Technolo- <br /> Technologies, Carlsbad, CA) antibiotic/antimycotic solution             gies). Briefly, cultured cells treated vehicle or <br /> (Sigma, St. Louis, MO).                                                     camptothecin 24 h. The cells stained Annexin V <br />                                                                             PI, subsequently analyzed FACSCalibur (Becton <br /> Preparation <span id='am-88' about='obo:NCBITaxon_36549' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-89' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:hasAlternativeId" content="NCBITaxon:2435" datatype="xsd:string"></span><span id='am-91' property="rdfs:label" content="plasmids" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span>plasmids</span> expressing DSCC1 E2Fs                           Dickinson, Franklin Lakes, NJ) using FlowJo software (Tree Star, <br />    The entire coding region DSCC1 cDNA (GenBank accession                Ashland, OR). <br /> No. NM_024094) amplified RT-PCR using set of <br /> primers; forward primer: 59-CCGGAATTCATGAAGAG-                              Cell viability assay <br /> GACCCGCGAC-39 reverse primer: 59-CGGCTCGAGA-                               Plasmids expressing short hairpin RNA (shRNA) using U6 <br /> GAAATGGGTCTTCTCGAATTAT-39 (underlined nucleotides                           promoter (psiU6BX3.0) prepared described previously <br /> indicate recognition sites restriction enzymes). The PCR             [12]. Plasmids expressing DSCC1 shRNA (psiU6-shDSCC1) were <br /> products cloned EcoRI XhoI sites pcDNA3.1/             constructed cloning double-stranded oligonucleotides the <br /> myc-His. We additionally generated plasmids expressing HA-                  BbsI sites psiU6BX3.0 vector. Two target sequences, 59- <br /> tagged DSCC1 (pCAGGS-DSCC1). The constructs pcDNA3-                         GUGGACAGAAGAAGAUAUU-39 (shDSCC1#1) 59- <br /> HA-E2Fs kindly provided Dr. J. R. Nevins (Duke                      GCAAACCAUAGGUGCAUUA-39 (shDSCC1#2), used <br /> University, Durham, NC).                                                    DSCC1 shRNAs. As negative controls, prepared plasmid <br />                                                                             targeting enhanced green fluorescent protein (psiU6-shEGFP) and <br /> Quantitative PCR gene copy number analysis                              targeting scrambled sequences shDSCC1#1 (59- <br />    Real-time PCR performed using LightCycler 480                    AAAUUGCGAAGGUGAUGAA-39; psiU6-shDSCC1#1scr) or <br /> system (Roche Diagnostics, Indianapolis, IN). Genomic DNAs                  shDSCC1#2 (59-AACACGUUAAUAACCGGUG-39; psiU6- <br /> were extracted CRC cell lines copy number analysis.                shDSCC1#2scr). Cell viability assays carried as <br /> Quantitative PCR performed ABI PRISM 7900HT                          described previously using HCT116, SW480, RKO cells <br /> Sequence Detection System, using FAM-labeled probes (59-                    transfected plasmids expressing shEGFP, shDSCC1, or <br />  <br />  <br /> PLOS ONE | www.plosone.org                                              2                          January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                    DSCC1 Is Novel Target E2F <br />  <br />  <br /> scramble shDSCC1 [11]. To investigate effect DSCC1                  normal colorectal tissues cDNA microarray [5]. Among the <br /> overexpression cell proliferation, transfected SW480             genes deregulated colorectal tumors, expression DNA <br /> HCT116 cells pCAGGS-DSCC1 established                      replication sister chromatid cohesion 1 (DSCC1) increased <br /> three clones stably expressing exogenous DSCC1. Control SW480              two-fold 5 7 colorectal cancers compared with <br /> and HCT116 cells transfected vector                   corresponding non-cancerous colon mucosa (Figure 1A). Subse- <br /> established mock cells.                                                 quent real-time PCR analysis using additional 20 CRC tissues <br />                                                                            corresponding non-cancerous mucosa revealed that <br /> Promoter reporter assays site-directed mutagenesis                     DSCC1 expression elevated two-fold 12 the <br />    Luciferase reporter plasmids containing DSCC1 promoter              20 tumors (Figure 1A). An immunohistochemical staining showed <br /> were prepared cloning 59-flanking region DSCC1          accumulated DSCC1 protein 29 40 CRC tissues compared <br /> MluI BglII restriction enzyme sites pGL3-Basic vector               corresponding adjacent non-cancerous colonic mucosa <br /> (Promega, Madison, WI). A DNA fragment approximately 1.0-               (Figure 1B). Although searched correlations its <br /> kb 59-flanking region DSCC1 amplified PCR using           expression clinicopathological factors including age sex of <br /> genomic DNA healthy volunteers set primers                   patients, location, size, histological data tumors such <br /> (forward:       59-CGACGCGTATGTCTGCTCAGATCCTTT-                            depth invasion, lymph node involvement, vascular or <br /> GAAT-39,        reverse:    59-GAAGATCTCGCCGGGTCTAG-                       lymphatic vessel invasion, factors significantly <br /> GAGTCC-39). Mutant plasmids containing substitutions                    associated DSCC1 expression (Table S1). Additionally, <br /> putative E2F binding sites DSCC1 promoter generated            western blot analysis using CRC cell lines revealed DSCC1 <br /> by site-directed mutagenesis using QuikChange II XL Site-              abundantly expressed HCT116, HT-29, DLD-1 cells, <br /> Directed Mutagenesis Kit (Agilent Technologies, Santa Clara,               expressed low levels SW480, SW620, and <br /> CA). Cells seeded 6-well plates transfected             Caco-2 cells (Figure 1C). Although compared stability of <br /> reporter plasmids pRL-TK (Promega) using                     DSCC1 protein HCT116 (DSCC1-high) SW480 (DSCC1- <br /> FuGENE 6 reagent. Cells harvested 24 hours                      low) cells cycloheximide chase assay, DSCC1 relatively <br /> transfection, reporter activities measured dual                stable HCT116 SW480 cells. Treatment with <br /> luciferase (TOYO B-Net, Tokyo, Japan). For knock-               MG132, proteasome inhibitor did enhance DSCC1 <br /> down E2F1 expression, synthetic E2F1 siRNA purchased                expression (Figure S1A). These data suggested protein <br /> from Sigma (sense: 59-GGGAGAAGUCACGCUAUGA-39, anti-                        stability likely play major role elevated expression <br /> sense: 59-AUAGCGUGACUUCUCCCCC-39).                                         DSCC1 cancer cells. <br />                                                                               Immunohistochemical analysis unexpectedly depicted accumu- <br /> Chromatin immunoprecipitation assay                                        lated DSCC1 cytoplasm nucleus DSCC1-positive <br />                                                                            cancer cells (Figure 1B), Dscc1 reported play a <br />    To investigate interaction E2F1 DSCC1 <br />                                                                            role establishment cohesion DNA replication in <br /> promoter region, chromatin immunoprecipitation (ChIP) assay <br />                                                                            yeast. To elucidate subcellular localization, carried out <br /> was performed according Agilent Mammalian ChIP <br />                                                                            immunocytochemical staining endogenous DSCC1 HCT116 <br /> protocol slight modifications. HCT116 cells cross-linked <br />                                                                            cells. Consistent immunohistochemical staining cancer <br /> with 1% formaldehyde 10 min room temperature and <br />                                                                            tissues, DSCC1 protein localized cytoplasm and <br /> quenched 0.4 M <span id='am-6' about='obo:NCBITaxon_3846' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_163735 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-7' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-8'  ></span><span id='am-9' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>glycine</span>. Chromatin extracts sheared by <br />                                                                            nucleus (Figure 1D S1B). Furthermore, western blot analysis <br /> micrococcal nuclease digestion, subsequently protein-DNA <br />                                                                            using cytoplasmic nuclear fractions extracted HCT116, <br /> complexes immunoprecipitated 3 mg anti-E2F1 <br />                                                                            RKO, DLD-1 cells (Figure 1E) cells expressing Myc- <br /> polyclonal antibody (C-20, Santa Cruz Biotechnology, Santa <br />                                                                            tagged DSCC1 confirmed subcellular localization the <br /> Cruz, CA) bound anti-rabbit IgG-coated Dynabeads (Life <br />                                                                            cytoplasm nucleus (Figure S1C S1D). <br /> Technologies). Non-immune rabbit IgG (Santa Cruz Biotechnol- <br /> ogy) used negative control. The precipitated DNAs were <br /> subjected quantitative PCR analysis primer set (forward          Copy number analysis DSCC1 <br /> (226) 59-CCGGAAACACGCCCATGGC-39 reverse (+127)                            To address gene amplification involved the <br /> 59-GGGTCCTCTTCATCGCAGC-39) amplify DSCC1                            DSCC1 overexpression, conducted copy number analysis by <br /> promoter region. Specificity assay determined            quantitative PCR using RNase P control. Compared with <br /> amplification distal upstream region DSCC1 promoter            peripheral leukocytes healthy volunteers, copy number of <br /> with following primers: forward (21279) 59-AGTTGTAGG-                  DSCC1 increased CRC cell lines tested (Figure 1F). <br /> GAATGTTTCCCATT-39                   reverse     (21111)      59-       It worth noting decrease copy number observed in <br /> GATTGGTTCATGTGACCTACTTC-39. In addition, am-                           HT-29 cells abundantly expressed DSCC1 (Figure 1C). We <br /> plifications cell division cycle 2 (CDC2) promoter                  analyzed copy number alteration DSCC1 colon and <br /> glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter                  rectum adenocarcinoma (The Cancer Genome Atlas Colorectal <br /> were used positive negative controls, respectively (primers:       Cancer project) using cBioPortal database (http://www. <br /> CDC2 forward 59-CGCCCTTTCCTCTTTCTTTC-39, CDC2                              cbioportal.org/public-portal/). As result, putative copy number <br /> reverse 59-ATCGGGTAGCCCGTAGACTT-39, GAPDH for-                             changes 7 257 colorectal adenocarcinomas <br /> ward 59-TACTAGCGGTTTTACGGGCG-39, GAPDH reverse                             (2.7%), suggesting amplification DSCC1 does play a <br /> 59-TCGAACAGGAGGAGCAGAGAGCGA-39).                                           major role enhanced DSCC1 expression. <br />  <br /> Results                                                                    Regulation DSCC1 promoter activity <br />                                                                               To resolve mechanism elevated DSCC1 expression in <br /> Expression DSCC1 frequently elevated CRC                          CRC, investigated promoter activity DSCC1 HCT116 <br />   In order identify novel target molecules treatment            cells. Reporter assay using plasmids containing 59-flanking <br /> and/or diagnostic biomarkers CRC, previously performed               region DSCC1 (pDSCC1-1023/+109) showed region <br /> expression profile analysis colorectal tumors matched         substantial promoter activity (data shown). In region, <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             3                           January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                      DSCC1 Is Novel Target E2F <br />  <br />  <br />  <br />  <br /> Figure 1. Expression DSCC1 colorectal tumors. (A) Relative expression ratios DSCC1 seven colorectal cancer tissues their <br /> corresponding normal tissues microarray data (upper panel). Relative expression levels DSCC1 additional 20 colorectal tumors the <br /> corresponding non-cancerous mucosa analyzed quantitative PCR (lower panel). Quantity DSCC1 normalized HPRT1 expression. Y <span id='am-72' about='obo:NCBITaxon_9855' typeof='owl:Thing obo:NCBITaxon_9850 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_91561 obo:NCBITaxon_35500 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_34878 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314145 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_9845'><span id='am-73' property="rdfs:label" content="Axis" datatype="xsd:string"></span><span id='am-74'  ></span><span id='am-75' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>axis</span> <br /> indicates ratio mean DSCC1 expression tumor corresponding normal tissue. The data represents mean 6 SD triplicate <br /> experiments. (B) Representative image immunohistochemical staining DSCC1 human colon cancer tissue containing cancer cells and <br /> adjacent normal mucosa. (C) Expression DSCC1 CRC cell lines detected western blotting using anti-DSCC1 antibody. (D) HCT116 cells <br /> were probed anti-DSCC1 antibody followed FITC-conjugated anti-mouse IgG secondary antibody (green). Nuclei counter-stained with <br /> DAPI (blue). (E) HCT116, RKO, DLD-1 cells separated cytoplasmic (CF) nuclear fractions (NF), cytoplasmic nuclear <br /> proteins subjected SDS-PAGE followed western blotting. Purity fractions determined presence b-tubulin (cytoplasmic <br /> marker) lamin B (nuclear marker). (F) Copy number analysis DSCC1 CRC cell lines HEK293 cells. Relative copy number DSCC1 <br /> gene determined quantitative PCR using RPPH1 endogenous reference. The copy number calculated dividing PCR products <br /> by peripheral leukocytes healthy volunteers, subsequently multiplying 2. <br /> doi:10.1371/journal.pone.0085750.g001 <br />  <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org                                               4                           January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                   DSCC1 Is Novel Target E2F <br />  <br />  <br /> we identified putative E2F-binding motif, EBS1 (23/+5; 59-               activation. To investigate DSCC1 expression is <br /> CTTGGCGC-39) using JASPAR (http://jaspar.genereg.net/)                 modulated E2F transcriptional activity, compared the <br /> and TFSEARCH databases (http://www.cbrc.jp/research/db/                    relative expression DSCC1 CDK1 (CDC2), readout of <br /> TFSEARCH.html) (Figure 2A). This putative binding site shared              E2F transcriptional activity, using independent data sets (E- <br /> high similarity consensus motif E2F, TTTSSCGC                 MEXP-3715 GEOD-23878) Gene Expression Atlas <br /> with S = G C. Since E2F transcription factors frequently            database (http://www.ebi.ac.uk/gxa/). In data sets, DSCC1 <br /> deregulated variety tumors, tested effect E2Fs        CDK1 significantly up-regulated colorectal tumors <br /> the DSCC1 promoter activity. Although E2F1, E2F2, E2F3,                compared normal colonic tissues (Figure 3). Notably, both <br /> E2F4 increased promoter activity, E2F6 did change              data sets calculated high values correlation coefficient (E- <br /> activity. E2F1, showed strongest induction             MEXP-3715, r = 0.912 GEOD-23878, r = 0.864) between <br /> four members, augmented activity dose-dependent fashion           DSCC1 CDK1, supporting view DSCC1 another <br /> (Figure 2B S2A). This enhancement observed                 downstream gene regulated E2F. <br /> other cell lines including LoVo, HeLa, HEK293 (data not <br /> shown). To examine possible involvement EBS1                 Effect DSCC1 proliferation CRC cells <br /> enhancement, measured reporter activity using constructs               To address role elevated expression CRC cells, we <br /> pDSCC1-10/+109 +10/+109 presence absence                  investigated DSCC1 involved proliferation of <br /> E2F1 (Figure 2C). Basal reporter activities reporter              cancer cells. We carried cell viability assay using plasmids <br /> plasmids significantly different absence E2F1           expressing DSCC1 shRNA (shDSCC1#1, shDSCC1#2) <br /> plasmids. Deletion EBS1 (pDSCC1+10/+109) dramatically                   neomycin resistant gene. Plasmids containing scrambled <br /> decreased E2F1-induced reporter activity (from 20.4-fold 3.2-           sequence DSCC1 shRNAs (shDSCC1#1scr and <br /> fold). Unexpectedly, enhancement reporter activity E2F1              shDSCC1#2scr) plasmid containing EGFP shRNA (shEGFP) <br /> was observed +10/+109. Further deletion +70          served controls. Transfection DSCC1 shRNAs <br /> promoter (pDSCC1+70/+109) completely diminished E2F1-                      (shDSCC1#1, shDSCC1#2) reduced expression of <br /> induced reporter activity (Figure 2C). In agreement              DSCC1, transfection controls (shEGFP, <br /> result, additional presumptive EBSs, EBS2 (+31/+              shDSCC1#1scr shDSCC1#2scr) effect (Figure 4A). <br /> 38; 59-CTTCCGGC-39) EBS3 (+57/+64; 59-TTGCCCGC-                        HCT116 cells cultured media containing appropriate <br /> 39) region +10 +70. To address responsibilities         concentration G418 cell viability measured. We <br /> of EBS1, EBS2, EBS3 induction, prepared                number viable cells transfected DSCC1#1 <br /> mutant reporter constructs (Figure 2D) substituting GC-rich         DSCC1#2 shRNA significantly decreased compared to <br /> segment E2F consensus motifs, TTTSSCGC (S = C G)                  transfected EGFP, DSCC1#1scr, DSCC1#2scr <br /> STTTS, core motifs reportedly crucial E2F           shRNA, indicating DSCC1 plays role viability of <br /> binding [13,14]. Compared wild type pDSCC1-10/+109                    cancer cells (Figure 4B). Consistent data obtained SW480 <br /> (14.8-fold induction), types EBS1-mutant plasmids                  RKO cells (Figure S3A). These results confirmed in <br /> (pDSCC1-10/+109 mut1, mut19) remarkably decreased                  repeated experiments. <br /> reporter activity response E2F1 (5.2-fold 5.8-fold,                 In addition, established SW480 cells constitutively <br /> respectively). Mutations EBS1 EBS2 (pDSCC1-10/+                express exogenous DSCC1, compared proliferation with <br /> 109 mut1+2) decreased E2F1-induced activity (3.7-           control cells transfected mock vector (Figure 4C). Consistent <br /> fold). Mutant reporter plasmid containing substitutions       DSCC1-knockdown data, cells expressing exogenous <br /> elements (pDSCC1-10/+109 mut1+2+3) diminished                   DSCC1 showed augmented cell proliferation compared to <br /> enhancement (1.7-fold), suggesting E2F binding              parental SW480 cells control cells (p = 2.261025). Similarly, <br /> motifs responsible regulation DSCC1 promoter                exogenous DSCC1-expression enhanced proliferation of <br /> activity.                                                                  HCT116 cells (Figure S3B). <br />  <br /> Interaction E2F1 DSCC1 promoter region                         Role DSCC1 induction apoptosis <br />    To determine E2F1 binds promoter region                  Since E2F1 conferred resistance genotoxic insults [15,16,17], <br /> DSCC1, performed quantitative ChIP assay using anti-E2F1                investigated elevated DSCC1 expression plays <br /> antibody set primers encompassing putative              role sensitivity cancer cells genotoxic stimuli. SW480 <br /> E2F-binding elements. The promoter cell division cycle 2 gene           cells-expressing exogenous DSCC1 (SW480-DSCC1#1, #3, and <br /> (CDC2), well-known E2F1 target, enriched 13.4-fold          #8) exposed c-irradiation, induction apoptosis was <br /> immunoprecipitated DNA (Figure S2B). Expectedly, DSCC1                 analyzed immunoblotting anti-cleaved PARP antibody. As <br /> promoter region enriched 15.4-fold DNA,                shown Figure 5A, quantification cleaved PARP-specific <br /> suggesting interaction DSCC1 promoter region                bands revealed c-irradiation led 3.9, 2.6, 1.2-fold <br /> E2F1 (Figure 2E).                                                          increase cleaved PARP control cells (SW480-Mock#1, #3, <br />    To confirm involvement E2F1 regulating DSCC1                  #4, respectively). On hand, 1.0, 1.4, 1.2-fold <br /> expression, investigated silencing effect E2F1 DSCC1          increase observed response c-irradiation SW480- <br /> expression. Real-time PCR western blot analyses showed            DSCC1#1, #3, #8 cells, respectively, suggesting that <br /> depletion E2F1 decreased DSCC1 expression (Figure 2F                DSCC1 suppressed apoptosis c-irradiation. In addition, <br /> S2C). RNAi-mediated knockdown E2F1 activity confirmed               treatment camptothecin, inhibitor topoisomerase I, <br /> by reporter assay showing significant reduction DSCC1               induced early apoptotic cells (annexin V-positive PI-low) by <br /> promoter activity 10.4 (Ctrl siRNA) 4.7-fold E2F1               5.662.9% control cells (Figure 5B), treatment <br /> siRNA SW480 cells (Figure 2G). These results suggested             increased early apoptotic cells 0.760.3% SW480- <br /> DSCC1 transactivation is, part, regulated E2F1           DSCC1 cells, indicating significant suppression apoptosis <br /> CRC interaction DSCC1 promoter region,            (p = 0.02). These data suggested elevated DSCC1 expression <br /> that EBSs play important role transcriptional          confer resistance apoptotic stimuli cancer cells. In <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             5                          January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                       DSCC1 Is Novel Target E2F <br />  <br />  <br />  <br />  <br /> Figure 2. Regulation DSCC1 promoter activity E2F transcription factor. (A) Nucleotide sequence 210 +90 bp region human <br /> DSCC1. Three putative E2F binding motifs underlined. (B) pDSCC1-1023/+109 transiently transfected pRL-TK pcDNA3 HA-E2Fs into <br /> SW480, pRL-TK pcDNA3 HA-E2F1 (0.01-1 mg) SW480 HCT116 cells. (C) pDSCC1-10/+109 shorter promoter constructs was <br /> transfected E2F1 vector SW480 cells. (D) Site-directed mutation analysis putative E2F binding sites proximal promoter <br /> region. pDSCC1-10/+109 mutant clones transfected E2F1 vector SW480 cells. The data represents mean 6 SD from <br /> three independent experiments. Promoter activity indicates relative luciferase unit fold induction vector transfectant. (E) <br /> Chromatin immunoprecipitation performed using anti-E2F1 antibody. The precipitated DNAs subjected amplification DSCC1 <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                6                           January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                     DSCC1 Is Novel Target E2F <br />  <br />  <br />  <br /> promoter quantitative PCR. To ascertain specific binding EBS, amplification distal upstream region DSCC1 promoter was <br /> used normalization. A significant difference determined t-test. (F) HCT116 cells transfected control E2F1 siRNA (25 nM) for <br /> 48 h. DSCC1 expression detected quantitative PCR. A significant difference determined t-test. (G) SW480 cells transfected with <br /> control E2F1 siRNA (25 nM), followed 8 h later transfection reporter plasmid (pDSCC1-10/+109) E2F1 expression vector empty <br /> vector. After 48 h, luciferase activity measured. The data represents mean 6 SD independent experiments. <br /> doi:10.1371/journal.pone.0085750.g002 <br />  <br /> complete agreement results, knockdown DSCC1                   imply suppression DSCC1 useful treatment <br /> potentiated camptothecin- c-irradiation-induced apoptosis            and/or chemosensitization CRC cells. <br /> HCT116 cells (Figure 5C S3C). To address DSCC1 <br /> expression affects cell death induced types cytotoxic           Discussion <br /> reagents, treated HCT116 cells doxorubicin, DNA <br /> intercalator, MG132, proteasome inhibitor, measured               Regulated retinoblastoma tumor suppressor, pRB, and/ <br /> cleavage PARP caspase-3, indicators apoptosis.                    related proteins, E2Fs play crucial roles cell cycle, nucleotide <br /> Suppression DSCC1 augmented cleavage PARP                     synthesis, DNA replication, DNA repair, apoptosis [18,19]. <br /> caspase-3 response doxorubicin, knockdown                  Activities E2Fs regulated integration signals <br />                                                                             transduced cellular DNA external environment. <br /> DSCC1 did increase cleavage response MG132 <br />                                                                             E2F1 thought act oncogene tumor suppressor, <br /> (Figure S3D S3E). Therefore, DSCC1 associated with <br />                                                                             action dependent cellular context. Indeed, <br /> the cell death caused DNA-damage, death by <br />                                                                             overexpression E2F1 observed CRC cells, suggesting its <br /> other types cytotoxic insults. Of note, DSCC1 depletion also <br />                                                                             tumorigenic role cancer [20]. E2F1 expression elevated in <br /> enhanced induction apoptosis c-irradiation p53-null <br />                                                                             lung metastasis colon cancer, correlates thymidylate <br /> HCT116 cells (Figure S3F), suggesting DSCC1-mediated <br />                                                                             synthase expression, resulting chemoresistance [21]. On the <br /> resistance apoptosis independent p53. These results <br />                                                                             hand, E2F1 over-expressed colon tumors increased <br />                                                                             apoptosis low proliferation [22]. Therefore, clarification of <br />                                                                             E2F1 targets clue versatile transcription <br />                                                                             factor family involved colorectal carcinogenesis. We have <br />                                                                             demonstrated DSCC1 frequently up-regulated in <br />                                                                             CRCs transactivation E2F family of <br />                                                                             transcription factors. Although DSCC1 located chromosomal <br />                                                                             region 8q, frequently amplified <br />                                                                             chromosomal regions colorectal tumors [23], copy number <br />                                                                             gain amplification involved DSCC1 up-regulation. <br />                                                                             Instead, showed flanking region DSCC1 <br />                                                                             transcription start site containing E2F regulatory sites (EBS1, <br />                                                                             2, 3) plays role transcriptional activation. A previous <br />                                                                             genome-wide ChIP-chip analysis reported 20,000&#8211;30,000 <br />                                                                             E2F1-biding sites distributed human genome, of <br />                                                                             51% overlapped transcription start sites [24]. The <br />                                                                             localization EBS1, 2, 3 compatible findings. <br />                                                                             Among sites, EBS1 EBS3 contain identical sequence <br />                                                                             core E2F1-binding motif (C/GC/GCGC), EBS2 <br />                                                                             contains 1-bp mismatch motif. Comparison human and <br />                                                                             mouse DSCC1 59-flanking sequences determined EBS1, <br />                                                                             located 23 +5 bp region, well-conserved between <br />                                                                             <span id='am-77' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-78' property="rdfs:label" content="species" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>species</span> (Figure S4A). Consistent data, the <br />                                                                             mutation EBS1 remarkably reduced E2F1-induced <br />                                                                             promoter activity three. Regarding regulatory <br />                                                                             elements, identified region 240 220 was <br />                                                                             associated basal promoter activity DSCC1 (Figure S4B). A <br />                                                                             search transcription factor-binding elements region found <br />                                                                             GC box encompassing putative ELK1-binding site, our <br />                                                                             reporter assay did significant change promoter <br />                                                                             activity ELK1 (data shown), suggesting ELK1 not <br />                                                                             involved regulation DSCC1. <br />                                                                                Eight members mammalian E2F family been <br />                                                                             recognized characterized. Among members, E2F1, <br />                                                                             E2F2, E2F3 categorized transcriptional activators, and <br />                                                                             E2F4, E2F5, E2F6, E2F7, E2F8 categorized repressors <br /> Figure 3. Positive correlation DSCC1 CDK1                       [25,26]. In promoter assay, E2F1, E2F2, E2F3, E2F4 <br /> expression colorectal tumors. This association shown              induced DSCC1 promoter activity, E2F6 did not, showing an <br /> two sets microarray data, E-MEXP-3715 (A) GEOD-23878 (B), in <br /> the Gene Expression Atlas database (http://www.ebi.ac.uk/gxa/). The <br />                                                                             inconsistent result E2F4 transcription. Molecular <br /> Pearson&#8217;s correlation coefficient (r) DSCC1 CDK1                studies uncovered E2Fs target genes regulated not <br /> expression values calculated assess correlation.          binding DNA element(s) their <br /> doi:10.1371/journal.pone.0085750.g003                                       interacting proteins Rb, p107, p130, polycomb group <br />  <br />  <br /> PLOS ONE | www.plosone.org                                              7                           January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                        DSCC1 Is Novel Target E2F <br />  <br />  <br />  <br />  <br /> Figure 4. Involvement DSCC1 CRC cell proliferation. (A) HCT116 cells transfected control (Mock EGFP) DSCC1 shRNAs <br /> for 48 h using Nucleofector kit, western blot analysis performed. Expression b-actin served control. (B) Viability cells transfected <br /> with shRNAs measured WST-8 assay. The data represents mean 6 SD independent transfections. P values calculated the <br /> Dunnett&#8217;s test multiple comparisons shEGFP-transfected cells. (C) Overexpression DSCC1 SW480 cells confirmed western blotting <br /> using anti-DSCC1 antibody. Equivalent number mock DSCC1 cells plated 96-well plates, cell proliferation assays were <br /> performed indicated time points. The data represents mean 6 SD experiments. A significant difference mock DSCC1 <br /> cells determined two-way repeated measures ANOVA. <br /> doi:10.1371/journal.pone.0085750.g004 <br />  <br /> proteins, histone-modification enzymes. Therefore,                    complex RFC2, RFC3, RFC4, RFC5. Depletion of <br /> factor(s) affect elevated promoter activity E2F4.                  DSCC1 reduces expression CTF18, induces decreased replica- <br /> Although direct association E2Fs cofactors                tion fork, increases collapse, suppresses recovery forks to <br /> the binding sites needs future detailed analysis, region              replication inhibitors, suggesting DSCC1 important for <br /> containing play vital role elevated                   DNA replication recovery genotoxic insults [30]. <br /> expression DSCC1.                                                               Global gene-gene interaction studies helped gain insights <br />    We showed time DSCC1 plays                        complex genetic networks yeast. These studies <br /> important role survival human cancer cells, enhanced                disclosed synthetic lethal combinations genetic dysfunction, <br /> expression DSCC1 induced survival cancer cells response                genetic variations individually effect on <br /> to c-irradiation, topoisomerase I inhibitor, DNA-intercalator.              cell viability cause cell death combined. The concept synthetic <br /> The data consistent finding Dscc1 mutants                     lethality great importance creating therapeutic approaches <br /> exhibit sensitivity c-irradiation <span id='am-17' about='obo:NCBITaxon_4932' typeof='owl:Thing obo:NCBITaxon_4930 obo:NCBITaxon_1 obo:NCBITaxon_4751 obo:NCBITaxon_131567 obo:NCBITaxon_4893 obo:NCBITaxon_33154 obo:NCBITaxon_451864 obo:NCBITaxon_4892 obo:NCBITaxon_4891 obo:NCBITaxon_4890 obo:NCBITaxon_716545 obo:NCBITaxon_147537 obo:NCBITaxon_2759'><span id='am-18' property="oboInOwl:hasExactSynonym" content="baker&apos;s yeast" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasRelatedSynonym" content="Saccaromyces cerevisiae" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasRelatedSynonym" content="Candida robusta" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasExactSynonym" content="brewer&apos;s yeast" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="lager beer yeast" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasExactSynonym" content="yeast" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces italicus" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasRelatedSynonym" content="Saccharomyes cerevisiae" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="Saccharomyces cerevisiae" datatype="xsd:string"></span><span id='am-29'  ></span><span id='am-30' property="oboInOwl:hasRelatedSynonym" content="Sccharomyces cerevisiae" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces uvarum var. melibiosus" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces capensis" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces oviformis" datatype="xsd:string"></span>Saccharomyces cerevisiae</span> [27,28].       selectively kill cancer cells, genetic and/or epigenetic <br /> Another study showed repair topoisomerase I inhibitor-                alterations expected cancer cells noncancerous <br /> induced DNA double-strand breaks, required components                        cells. For example, PARP inhibitors shown induce <br /> chromatid cohesion including Csm3, Tof1, Mrc1, Dscc1 [29].                  synthetic lethality cancer cells BRCA1 BRCA2 <br /> Alternatively, DSCC1 enhance recombination repair                       mutations [31,32]. Of note, McLellan colleagues validated <br /> through CTF18-RFC complex. Our study additionally showed                    genetic interactions synthetic lethality yeast ctf8, <br /> that resistance independent p53                 ctf18, dscc1, ctf4, rad27 genes required the <br /> induction apoptosis potentiated HCT116 p532/2                    maintenance chromosomal stability [6]. They additionally <br /> cells (Figure S3F). Associated CTF8, DSCC1 forms                        showed genetic interactions conserved Caenorhab- <br /> alternate RFC CTF18, stabilizes 7-subunit                      ditis elegans, suggesting potential utility genes the <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                  8                           January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                      DSCC1 Is Novel Target E2F <br />  <br />  <br />  <br />  <br /> Figure 5. DSCC1 alters sensitivity apoptotic stimuli. (A) SW480 cells stably expressing DSCC1 mock (empty vector) exposed c- <br /> irradiation (5 Gy). The cells harvested 24 h exposure, lysates subjected western blot analysis. (B) SW480 cells stably <br /> expressing DSCC1 mock treated camptothecin (CPT, 30 mM). The cells harvested 24 h treatment, cell suspensions <br /> were subjected annexin V staining. The data represents mean 6 SD different clones. Increased annexin V-positive cell population by <br /> treatment CPT compared control (Mock) DSCC1-expressing cells. A significant difference determined t-test. (C) HCT116 <br /> cells transfected control DSCC1 siRNA, treated CPT (30 mM) 48 h. The cells harvested 24 h CPT-treatment, and <br /> the lysates subjected western blot analysis. <br /> doi:10.1371/journal.pone.0085750.g005 <br />  <br />  <br /> PLOS ONE | www.plosone.org                                               9                           January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                                        DSCC1 Is Novel Target E2F <br />  <br />  <br /> treatment colorectal tumors CIN frequently involved                     cells. (B) Overexpression DSCC1 HCT116 cells was <br /> the carcinogenesis. They showed mutations ctf4, ctf8, ctf18,                   confirmed western blot analysis anti-Flag antibody. <br /> and dscc1 synthetically lethal combined mutations                     Equivalent number mock clones, DSCC1 clones, and <br /> CIN genes including mre11, smc1, smc3, scc2, pds1 [6]. To test                     parental HCT116 cells plated 96-well plates, cells <br /> whether CTF18-RFC complex associated chemo-                                cultured medium containing 0.5% FBS. Cell proliferation <br /> sensitivity, CTF18, member CTF18-RFC complex,                                 assays performed indicated time points. The data <br /> knocked HCT116 cells. Interestingly, silencing CTF18                        represents mean 6 SD experiments. (C) HCT116 cells <br /> resulted increased cell death response camptothecin                       treated control DSCC1 siRNA (10 nM), followed <br /> (Figure S4C). Although studies molecular mechanism(s)                       48 h later exposure c-irradiation (5 Gy). (D, E) HCT116 <br /> underlying DSCC1- CTF18-mediated chemoresistance                            cells treated control DSCC1 siRNA (10 nM), <br /> are needed, data imply DSCC1 facilitate DNA                         followed 48 h later treatment doxorubicin (5 mM) or <br /> repair homologous recombination regulation                           MG132 (2 mM). (F) HCT116 p53-/- cells treated with <br /> this complex. If case, inhibition DSCC1                              control DSCC1 siRNA (10 nM), followed 48 h later by <br /> combination treatment inducing genotoxic insults                          exposure c-irradiation (5 Gy). The cells harvested 24 h <br /> camptothecin c-irradiation effective therapeutic                         exposure, lysates subjected western blot <br /> option. Comprehension DNA damage, repair activities,                            analysis. <br /> anti-apoptotic abilities needed clarify threshold                     (TIF) <br /> for apoptosis cell. <br />                                                                                        Figure S4 Alignment human mouse DSCC1 59- <br />    In summary, data clue understanding of <br />                                                                                        flanking sequence. (A) Alignment human mouse DSCC1 <br /> new molecular mechanisms underlying resistance cancer cells <br />                                                                                        59-flanking sequence DBTSS database (http://dbtss.hgc. <br /> against genotoxic insults, contribute development <br />                                                                                        jp/). Top strand represents 59-flanking sequences human <br /> of new strategies overcome chemoresistance anti-cancer <br />                                                                                        DSCC1, strand represents 59-flanking <br /> drugs. <br />                                                                                        sequences mouse Dscc1. E2F binding motifs underlined. <br />                                                                                        (B) pDSCC1-133/+109 shorter promoter constructs was <br /> Supporting Information                                                                 transfected pRL-TK SW480 cells. The promoter activity <br /> Figure S1 Subcellular localization DSCC1. (A) HCT116                                measured luciferase activity. Each value represents mean 6 <br /> and SW480 cells treated MG132 (10 mM, 6 h)                                SD independent transfections. (C) The effect CTF18 <br /> cycloheximide (100 mg/ml). The cells harvested                             siRNA (S: 59-CCAACUGCCUGGUCAUCG-39, AS: 59-UC- <br /> indicated time points, lysates subjected western                       GAUGACCAGGCAGUUG-39) evaluated quantitative <br /> blot analysis. (B) High magnification images Figure 1D (x180).                      PCR (CTF18 primers, forward: 59-CTTCTCGGTGTGGCA- <br /> (C) HCT116 cells expressing Myc-tagged DSCC1 probed                               GGA-39, reverse: 59-CAGCAGGAGTGTGTCAGCAG-39). <br /> with anti-Myc antibody followed FITC-conjugated anti-mouse                          HCT116 cells treated control CTF18 siRNA <br /> IgG secondary antibody (green). Nuclei counter-stained                       (10 nM), followed 48 h later treatment CPT (30 mM). <br /> DAPI (blue). (D) The cytoplasmic nuclear proteins                             The cells harvested 24 h treatment, lysates were <br /> analyzed western blotting.                                                          subjected western blot analysis. <br /> (TIF)                                                                                  (TIF) <br /> Figure S2 Regulation DSCC1 E2Fs. (A) HEK293T                                     Table S1   Correlations DSCC1 expression and <br /> cells transfected pcDNA3 HA-E2F1, -E2F2, -E2F3, -                            clinicopathological characteristics 40 colon <br /> E2F4, -E2F6 24 h, lysates subjected                            cancer patients. <br /> western blot analysis. (B) Chromatin immunoprecipitation                           (XLS) <br /> performed using anti-E2F1 antibody. The precipitated DNAs were <br /> subjected amplification CDC2 promoter quantitative                        Acknowledgments <br /> PCR. (C) HeLa cells transfected control E2F1 siRNA <br />                                                                                        We thank Masashi Miura, <span id='am-54' about='obo:NCBITaxon_186261' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_730330 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_187688 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_48704 obo:NCBITaxon_33154 obo:NCBITaxon_6656 obo:NCBITaxon_79707 obo:NCBITaxon_79744 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_30001 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_181623 obo:NCBITaxon_6072 obo:NCBITaxon_6960'><span id='am-55' property="rdfs:label" content="Seira" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-57'  ></span><span id='am-58' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Seira</span> Hatakeyama, Hiromi Toyoda (The <br /> (25 nM) 48 h. Western blot analysis performed using                        University Tokyo) technical assistance Yumiko Ishii <br /> indicated antibodies.                                                                  (IMSUT FACS Core Laboratory) assistance flow cytometry. <br /> (TIF) <br /> Figure S3     DSCC1 alters response genotoxic insults.                              Author Contributions <br /> (A) Viability cells transfected shRNAs measured                         Conceived designed experiments: KY YF. Performed the <br /> WST-8 assay. The data represents mean 6 SD                          experiments: KY NT. Analyzed data: RY AN SI SM. Contributed <br /> independent transfections. P values calculated                           reagents/materials/analysis tools: TI TF MS GT KH YN. Wrote the <br /> Dunnett&#8217;s test multiple comparisons shEGFP-transfected                          paper: KY YF. <br />  <br /> References <br /> 1. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C (2003) The significance           5. Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC, et al. (2002) Molecular <br />    unstable chromosomes colorectal cancer. Nat Rev Cancer 3: 695&#8211;701.               diagnosis colorectal tumors expression profiles 50 genes expressed <br /> 2. Wang Z, Cummins JM, Shen D, Cahill DP, Jallepalli PV, et al. (2004) Three              differentially adenomas carcinomas. Oncogene 21: 4120&#8211;4128. <br />    classes genes mutated colorectal cancers chromosomal instability.        6. McLellan J, O&#8217;Neil N, Tarailo S, Stoepel J, Bryan J, et al. (2009) Synthetic lethal <br />    Cancer Res 64: 2998&#8211;3001.                                                              genetic interactions decrease somatic cell proliferation <span id='am-49' about='obo:NCBITaxon_6237' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_119089 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_55879 obo:NCBITaxon_131567 obo:NCBITaxon_55885 obo:NCBITaxon_6236 obo:NCBITaxon_33154 obo:NCBITaxon_6231 obo:NCBITaxon_1206794 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6243 obo:NCBITaxon_6072'><span id='am-50' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-51' property="rdfs:label" content="Caenorhabditis" datatype="xsd:string"></span><span id='am-52'  ></span><span id='am-53' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Caenorhabditis</span> <br /> 3. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, et al. (2008)                     elegans identify alternative RFC CTF18 candidate cancer drug target. <br />    Chromatid cohesion defects underlie chromosome instability human                Mol Biol Cell 20: 5306&#8211;5313. <br />    colorectal cancers. Proc Natl Acad Sci U S A 105: 3443&#8211;3448.                        7. Bermudez VP, Maniwa Y, Tappin I, Ozato K, Yokomori K, et al. (2003) The <br /> 4. Mayer ML, Gygi SP, Aebersold R, Hieter P (2001) Identification                      alternative Ctf18-Dcc1-Ctf8-replication factor C complex required sister <br />    RFC(Ctf18p, Ctf8p, Dcc1p): alternative RFC complex required sister              chromatid cohesion loads proliferating cell nuclear antigen DNA. Proc Natl <br />    chromatid cohesion S. cerevisiae. Mol Cell 7: 959&#8211;970.                              Acad Sci U S A 100: 10237&#8211;10242. <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                        10                               January 2014 | Volume 9 | Issue 1 | e85750 <br />                                                                                                                                              DSCC1 Is Novel Target E2F <br />  <br />  <br />  8. <span id='am-59' about='obo:NCBITaxon_9596' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_9526 obo:NCBITaxon_9604 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_314293 obo:NCBITaxon_314295 obo:NCBITaxon_376913 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_207598 obo:NCBITaxon_9443'><span id='am-60' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasAlternativeId" content="NCBITaxon:317028" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasExactSynonym" content="chimpanzees" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasAlternativeId" content="NCBITaxon:445518" datatype="xsd:string"></span><span id='am-64' property="rdfs:label" content="Pan" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-66'  ></span>Pan</span> X, Ye P, Yuan DS, Wang X, Bader JS, et al. (2006) A DNA integrity                   21. Banerjee D, Gorlick R, Liefshitz A, Danenberg K, Danenberg PC, et al. (2000) <br />     network yeast <span id='am-34' about='obo:NCBITaxon_4930' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_4751 obo:NCBITaxon_4893 obo:NCBITaxon_33154 obo:NCBITaxon_451864 obo:NCBITaxon_4892 obo:NCBITaxon_4891 obo:NCBITaxon_4890 obo:NCBITaxon_716545 obo:NCBITaxon_2759 obo:NCBITaxon_147537'><span id='am-35'  ></span><span id='am-36' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="Saccharomyces" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasAlternativeId" content="NCBITaxon:36915" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasRelatedSynonym" content="Pachytichospora" datatype="xsd:string"></span>Saccharomyces</span> cerevisiae. Cell 124: 1069&#8211;1081.                         Levels E2F-1 expression higher lung metastasis colon cancer as <br />  9. Tong AH, Lesage G, Bader GD, Ding H, Xu H, et al. (2004) Global mapping                  compared hepatic metastasis correlate levels thymidylate <br />     yeast genetic interaction network. Science 303: 808&#8211;813.                                synthase. Cancer Res 60: 2365&#8211;2367. <br /> 10. Gellon L, Razidlo DF, Gleeson O, Verra L, Schulz D, et al. (2011) New                   22. Zacharatos P, Kotsinas A, Evangelou K, Karakaidos P, Vassiliou LV, et al. <br />     functions Ctf18-RFC preserving genome stability outside role sister            (2004) Distinct expression patterns transcription factor E2F-1 relation to <br />     chromatid cohesion. PLoS Genet 7: e1001298.                                                 tumour growth parameters common human carcinomas. J Pathol 203: 744&#8211; <br /> 11. Yamaguchi K, Sakai M, Shimokawa T, Yamada Y, Nakamura Y, et al. (2010)                      753. <br />     C20orf20 (MRG-binding protein) potential therapeutic target colorectal         23. Meijer GA, Hermsen MA, Baak JP, van Diest PJ, Meuwissen SG, et al. (1998) <br />     cancer. Br J Cancer 102: 325&#8211;331.                                                           Progression colorectal adenoma carcinoma associated non- <br /> 12. Shimokawa T, Furukawa Y, Sakai M, Li M, Miwa N, et al. (2003) Involvement                   random chromosomal gains detected comparative genomic hybridisation. <br />     FGF18 gene colorectal carcinogenesis, novel downstream target             J Clin Pathol 51: 901&#8211;909. <br />     <span id='am-11' about='obo:NCBITaxon_3554' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_3563 obo:NCBITaxon_91827 obo:NCBITaxon_71240 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_3524 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_3193'><span id='am-12' property="rdfs:label" content="Beta" datatype="xsd:string"></span><span id='am-13'  ></span><span id='am-14' property="oboInOwl:hasRelatedSynonym" content="Beta L. 1753" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>beta</span>-catenin/T-cell factor complex. Cancer Res 63: 6116&#8211;6120.                       24. Bieda M, Xu X, Singer MA, Green R, Farnham PJ (2006) Unbiased location <br /> 13. Zheng N, Fraenkel E, Pabo CO, Pavletich NP (1999) Structural basis DNA                   analysis E2F1-binding sites suggests widespread role E2F1 human <br />     recognition heterodimeric cell cycle transcription factor E2F-DP. Genes              genome. Genome Res 16: 595&#8211;605. <br />     Dev 13: 666&#8211;674.                                                                        25. DeGregori J, Johnson DG (2006) Distinct Overlapping Roles E2F <br />                                                                                                 Family Members Transcription, Proliferation Apoptosis. Curr Mol Med <br /> 14. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, et al. (2007) A <br />                                                                                                 6: 739&#8211;748. <br />     comprehensive ChIP-chip analysis E2F1, E2F4, E2F6 norm <br /> </body></html>